CD-sACE2 Inclusion Compounds: An Effective Treatment for Corona Virus Disease 2019 (COVID-19).

Clicks: 359
ID: 102902
2020
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #15 of 39 articles by views in Journal of medical virology

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
ACE2 is a metalloproteinase and a homolog of carboxypeptidase ACE. It hydrolyzes a variety of angiotensin peptides and is the main active peptide of the renin-angiotensin system (RAS). ACE2, which is made of 805 amino acids, is a type I transmembrane glycoprotein with a single extracellular catalytic domain. This article is protected by copyright. All rights reserved.
Reference Key
sun2020cdsace2journal Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Sun, Pengfei;Lu, Xiaosheng;Xu, Chao;Wang, Yanjin;Sun, Wenjuan;Xi, Jianing;
Journal Journal of medical virology
Year 2020
DOI
10.1002/jmv.25804
URL
Keywords
coronavirus cyclodextrin covid-19 2019-ncov ace2

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.